FDA Postpones Foreign Inspections Due To Coronavirus Outbreak
Critical Inspections Will Be Considered Case-By-Case
The US FDA is postponing “most foreign inspections” through April as a result of the coronavirus outbreak, because it will temporarily not be able to physically inspect foreign produced FDA-regulated products or manufacturers. However, inspections outside the US deemed as critical “will still be considered on a case-by-case basis.”
